Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0000950170-24-097097

Director sold 35,000 shares at an average $26.08 ($912,961)

  • Director disposed of 74,892 shares (other)
  • Director acquired 37,562 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LINK WILLIAM J PHD Director 2024-08-12 Other disposition −74,892 35,000 I: show line 1 in the form
LINK WILLIAM J PHD Director 2024-08-12 Other acquisition +10,446 10,446 I: show line 2 in the form
LINK WILLIAM J PHD Director 2024-08-12 Other acquisition +27,116 167,098 D: show line 3 in the form
LINK WILLIAM J PHD Director 2024-08-12 Sale −29,979 $26.01 $779,754 5,021 I: show line 4 in the form
LINK WILLIAM J PHD Director 2024-08-12 Sale −5,021 $26.53 $133,207 0 I: show line 5 in the form
Open-market sales · 35,000 sh · avg $26.08 · $912,961
Loading xslF345X05/ownership.xml…